Clinical Trial Update: Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC) [EARLY_Phase 1]

View source ↗

Summary

Early-phase window study evaluating intratumoral mitazalimab in breast cancer; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Mitazalimab (mitazalimab)

Snippet

Sponsor: Jennifer Zhang | Conditions: Breast Cancer | EARLY_Phase 1 | Status: NOT_YET_RECRUITING